Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Reference28 articles.
1. Prior TW, Finanger E. Spinal Muscular Atrophy. 2000 Feb 24 [Updated 2016 Dec 22]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1352/
2. Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, Kaufmann P (2007) The changing natural history of spinal muscular atrophy type 1. Neurology. 69:1931–1936
3. Prior TW, Nagan N, Sugarman EA, Batish SD, Braastad C (2011 Jul) Technical standards and guidelines for spinal muscular atrophy testing. Genet Med. 13(7):686–694
4. Wurster CD, Ludolph AC (2018) Nusinersen for spinal muscular atrophy. Ther Adv Neurol Disord 11:1756285618754459
5. Aartsma-Rus A (2017 Apr) FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides. Nucleic Acid Ther 27(2):67–69
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献